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Acellular Dermal Matrix for Mucogingival Surgery:
A Meta-Analysis
Ricardo Gapski,* Christopher Allen Parks,* and Hom-Lay Wang†
Background: Many clinical studies revealed the effectiveness of acel-
lular dermal matrix (ADM) in the treatment of mucogingival defects. The
purpose of this meta-analysis was to compare the efficacy of ADM-based
root coverage (RC) andADM-based increase inkeratinized tissues toother
commonly used mucogingival surgeries.
Methods: Meta-analysis was limited to randomized clinical trials (RCT).
Articles from January 1, 1990 to October 2004 related to ADM were
searched utilizing the MEDLINE database from the National Library of Med-
icine, the Cochrane Oral Health Group Specialized Trials Registry, and
through hand searches of reviews and recent journals. Relevant studies
were identified, ranked independently, and mean data from each were
weighted accordingly. Selected outcomeswere analyzed using ameta-anal-
ysis softwareprogram.Thesignificant estimatesof the treatmenteffects from
different trials were assessed by means of Cochrane’s test of heterogeneity.
Results: 1) Few RCT studies were found to compile the data. In sum-
mary, selection identified eight RCT that met the inclusion criteria. There
were four studies comparing ADM versus a connective tissue graft for
root coverage procedures, two studies comparing ADM versus coronally
advanced flap (CAF) for root coverage procedures, and two studies com-
paring ADM to free gingival graft in augmentation of keratinized tissue. 2)
There were no statistically significant differences between groups for any
of the outcomesmeasured (recession coverage, keratinized tissue forma-
tion, probingdepths, andclinical attachment levels). 3)Themajority of the
analyses demonstrated moderate to high levels of heterogeneity. 4) Con-
sidering the heterogeneity values found among the studies, certain trends
could be found: a) three out of four studies favored the ADM-RC group for
recession coverage; b) a connective tissue graft tended to increase kerati-
nized tissue compared to ADM (0.52-mm difference; P = 0.11); c) there
were trends of increased clinical attachment gains comparing ADM to
CAF procedures (0.56-mm difference; P = 0.16).
Conclusions: Differences in study design and lack of data precluded an
adequate and complete pooling of data for amore comprehensive analysis.
Therefore, considering the trends presented in this study, there is a need for
further randomized clinical studies of ADM procedures in comparison to
commonmucogingival surgical procedures to confirmour findings. It is dif-
ficult to drawanythingother than tentativeconclusions from thismeta-anal-
ysis ofADM formucogingival surgery, primarily becauseof theweakness in
the design and reporting of existing trials. J Periodontol 2005;76:1814-1822.
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I
n recent decades, several
surgical procedures have
been proposed for the treat-
ment of gingival recession and
to increase the width of at-
tached gingiva. These surgical
procedures include pedicle soft
tissue flaps, autogenous free
soft tissue grafts, combination
free/pedicle soft tissue grafts
for treatment of recession and
periosteal retention, denuda-
tion procedures, and free gingi-
val grafts for gain in the width
of keratinized gingiva (KG).1-9
Researchhasdemonstratedsu-
perior esthetics andpredictable
outcomes in treating gingival
recession in terms of the per-
centage of root coverage (RC)
when a free autogenous con-
nective tissue graft (CTG) is
utilized,10 while a free gingival
graft (FGG)remains thechosen
method inaugmenting the zone
of keratinized gingiva.11,12
The disadvantages of har-
vesting free autogenous soft
tissuegrafts lie in thepostoper-
ative discomfort associated
with an extra surgical site, as
well as the limitations of avail-
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graft,13,14 lyophilized homologous dura mater,15-17
andabsorbableandnon-absorbablemembranes.18-21
Recently, an acellular dermal matrix (ADM) allo-
graft‡ was approved as a substitute for autogenous
grafts in mucogingival surgeries. The preparation
of this dermal allograft involves cell component
removal and preservation of the ultrastructural in-
tegrity, which if damaged would induce an inflam-
matory response.22-24 ADM was originally utilized
for use in plastic surgery for the treatment of full-
thickness burn wounds.22 Over the last few years,
several studies have evaluated the effect of ADM for
mucogingival surgery with promising results.25-40
Overall, most ADM studies included a small sample
size that lacked sufficient statistical power to draw
conclusions regarding the efficacy of ADM. There-
fore, the aim of this present investigation was to per-
form a meta-analysis of the available literature to
evaluate 1) the efficacy of ADM tissue on percent
root coverage and changes in CAL and PD versus
coronally advanced flap (CAF) and CTG and 2)
the efficacy of ADM in gaining KG versus FGG
and CTG. The null hypothesis is that there is no sta-
tistical difference in treating patients with ADM as
compared to traditional surgical modalities. Hence,
the focused question was as follows: In patients with
gingival recessions and/or lacking keratinized tis-
sue, is there a benefit in treating the patient with
acellular dermal matrix as compared to traditional




Three data sources were utilized for this review: 1) the
MEDLINE database from the National Library of
Medicine using the Ovid interface; 2) Cochrane Oral
Health Group Specialized Trials Registry (The Co-
chrane Library); and 3) hand searching of specific
journals including the International Journal of Peri-
odontics & Restorative Dentistry, Journal of Clinical
Periodontology, Journal of Periodontology, Journal
of Periodontal Research, and bibliographies of review
and investigational papers. No attempt was made to
contact researchers in this field to obtain original data
or fugitive literature (e.g., unpublished studies). Ar-
ticles from January 1, 1990 to October 2004 were
prescreened using the following key words (italics):
acellular humanmatrixOR acellular dermalmatrix al-
lograft OR dermal matrix allograft OR Alloderm OR
root coverage OR keratinized gingiva OR gingival re-
cessionOR soft tissueOR tooth root surgeryOR grafts
OR surgical flaps. Titles and abstracts of studies iden-
tified according to the inclusion criteria were then
screened independently by the reviewers. Selected
full-text studies were subsequently evaluated inde-
pendently by the same reviewers using the same cri-
teria.
Inclusion Criteria
The following inclusion criteria were applied: 1) pub-
lished in English; 2) 3 months of duration to ensure
Table 1.
















ADM-based root coverage versus CTG
Aichelmann-Reidy
et al.35
Miller I-II 22 44 Yes Yes No ADM-RC CTG
Novaes et al.41 Miller I-II 9 30 Unclear Unclear No ADM-RC CTG
Tal et al.42 Miller I-II 7 14 Yes Yes No ADM-RC CTG
Barros et al.40 Miller I-II 14 32 Unclear Unclear No ADM-RC CTG
ADM-based root coverage versus CAF
Woodyard et al.27 Miller I-II 24 24 Yes Yes Unclear ADM-RC CAF
Cortes et al.43 Miller I 13 26 Unclear Unclear No ADM-RC CAF
ADM-based augmentation of KG versus FGG
Wei et al.29 NA 12 12 Yes Unclear Unclear ADM-KG FGG
Harris34 NA 30 30 No Unclear No ADM-KG FGG
SS = statistically significant; NA = not applicable; ADM-KG = acellular dermal matrix for increasing keratinized gingiva.
‡ Alloderm, Life Cell Corporation, The Woodlands, TX.
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that the follow-up of the patients were sufficiently
long; 3) randomized controlled clinical trials; and 4)
studies from January 1, 1990 to October 2004. Mul-
tiple reports utilizing the same database or population
were identified, and only data from themost recent re-
port was used. Control groups were only included if
they were CAF or CTG for root coverage procedures
or FGG and CTG for increasing the amount of kerati-
nized tissue.When comparisonswere utilized between
ADM-based root coverage, onlyMiller Class I and/or II
were included in the analysis. Another inclusion crite-
rion was studies that assessed systemically healthy
adult patients. Studies were not excluded on the basis
of quality, only whether they fulfilled the inclusion
criteria for entry.
Type of Intervention and Outcomes Measured
The intervention of interest wasmucogingival surgery
for root coverage or augmentation of keratinized tis-
sue. The primary outcomes selected for this analysis
were the amount of root coverage and changes in the
width of keratinized tissue, while secondary outcomes
included changes in clinical attachment levels (CAL)
and probing depths (PD).
Validity Assessment
Titles and abstracts were screened for possible rele-
vance by the investigators. For all studies of possible
relevance, the full text was retrieved. Two reviewers
(CAP and RG) independently extracted data from all
primary studies fulfilling eligibility criteria. Any dis-
crepancies in extracted data were resolved by con-
sensus; the K-score for agreement was 0.78. Data
extracted included the focus of the study, details of
study protocol, demographic data, and reported out-
comes. Studies were evaluated for randomization,
masking, inclusion of control comparisons, anddiffer-
ences in baseline measurements.
Data Collection and Statistical Analysis
Study grouping was based on therapeutic modalities
investigated, outcomes measured, and the quality of
studies. For the studies that could be included in the
meta-analysis, aweighted treatment effect was calcu-
lated, and the results were expressed as weighted
mean differences (WMD and 95% confidence inter-
vals [CI]) for continuous outcomes. Some of the stud-
ies did not report the standard deviation of the mean
difference. In this case, the equation for the SD of
Table 2.





BL End D BL End D
Aichelmann-Reidy et al.35 6 months ADM 2.5 – 0.8 0.8 – 1.0 1.7 – 1.2 1.1 – 1.0 1.3 – 1.0 0.2 – 1.0
CTG 3.0 – 0.7 0.8 – 1.1 2.2 – 1.1 1.1 – 0.8 1.7 – 1.2 0.6 – 1.0
Barros et al.40 6 months ADM 3.9 – 0.87 0.9 – 0.64 3.6 –.6.04 1.6 – 0.51 1.3 – 0.45 -0.2 – 0.54
CTG 3.4 – 0.94 1.3 – 0.7 2.1 – 0.97 1.6 – 0.51 1.5 – 0.50 -0.1 – 0.66
Novaes et al.41 6 months ADM 3.23 – 1.08 1.13 – 1.08 2.10 – 1.00 1.29 – 0.57 1.43 – 0.37 0.13 – 0.60
CTG 2.97 – 0.81 1.13 – 1.06 1.83 – 0.83 1.52 – 0.47 1.43 – 0.58 -0.09 – 0.75
Tal et al.42 12 months ADM 5.14 – 0.9* 0.57 – 0.6* 4.57 – 0.9* 1.64 – 0.2* 1.86 – 0.5* 0.22 – 0.3*
CTG 4.86 – 0.9* 0.57 – 0.5* 4.29 – 0.9* 1.50 – 0.5* 1.50 – 0.2* 0.0 –.4 01*
Cortes et al.43 6 months ADM 3.46 – 0.85 0.88 – 0.89 2.58 – 0.67 1.27 – 0.44 1.73 – 0.39 0.46 – 0.56
CAF 3.58 – 0.57 1.08 – 0.84 2.50 – 0.64 1.27 – 0.33 1.85 – 0.43 0.58 – 0.57
Woodyard et al.27 6 months ADM 3.46 – 0.89 0.04 – 0.14 3.42 – 0.93 1.42 – 0.51 1.17 – 0.39 -0.25 – 0.62
CAF 3.27 – 0.56 1.08 – 0.90 2.19 – 0.95 1.67 – 0.65 1.17 – 0.39 -0.50 – 0.90
Harris34 3 months ADM ND ND ND ND ND ND
FGG ND ND ND ND ND ND
Wei et al.29 6 months ADM 2.52 – 1.98 2.75 – 2.02 -0.23 – 2.8‡ 1.26 – 0.3 1.05 – 0.15 -0.21 – 0.3‡
FGG 1.76 – 1.49 1.86 – 1.41 -0.1 – 1.8‡ 1.01 – 0.03 1.27 – 0.2 -0.26 – 0.2‡
* SD values calculated from patient data.
† CAL + SD calculated from given individual patient data.
‡ SD calculated from the square root of the sum of the variances of the measures (assuming the covariance between therapies was zero).
KT = keratinized tissue; BL = baseline; ND = no data could be retrieved.
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the difference was calculated from the square root of
the sum of the variances of the measures, minus the
covariance of the measurements. In determining the
standard deviation of the difference between groups,
the conservative assumption was made that the co-
variance between therapies was zero. Then, primary
and secondary outcomes were analyzed.§ The signif-
icant estimates of the treatment effects from different
trials were assessed by means of Cochrane’s test of
heterogeneity.
RESULTS
Details of Included Studies
The initial application of described search strategies
resulted in the identification of 105 publications. Fur-
ther screening by the primary reviewer identified 40
articles appropriate for full review by both reviewers.
Of these 40 articles, eight studies were selected based
on the criteria for inclusion. Themost common reason
for study exclusion was the lack of a control group,
lack of randomization, or lack of outcome measured.
In summary, four studies were eligible for com-
parisons between ADM-based root coverage and
CTG,35,40-42 two for comparisons between ADM-
based root coverage and CAF27,43 and two for com-
parisons between ADM-based augmentation of KG
and FGG.29,34 For all these subgroups, the groups
were treated equally apart from the experimental ther-
apy. The characteristics of the included studies are
shown in Tables 1 and 2.
Quality Assessment of Studies
The evaluation of the quality of the included studies
was impaired due to the failure of many reports to
provide sufficient information allowing for accurate
assessment. Four of the eight studies reported
masked examiners,27,29,35,42 while three studies did
not report information regarding masking.40,41,43
One studywas unmasked.34Only randomized studies
were included for the analysis. Methods of random-
ization for these studies varied. Five of the eight
studies failed to report the method of randomiza-
tion,27,29,34,40,41while three studies presented appro-
priate randomization mechanisms.27,35,42 Among all
Table 2. (continued)
Mean and Standard Deviation From the Included Studies
CAL KT
BL End D BL End D
3.6 – 0.9 2.1 – 1.0 1.5 – 1.1 1.7 – 0.7 2.9 – 1.2 1.2 – 1.3
4.1 – 0.8 2.5 – 1.3 1.6 – 1.1 1.8 – 1.2 3.5 – 1.2 1.6 – 1.9
14.1 – 1.71 12.5 – 1.39 1.6 – 0.98 2.0 – 1.16 3.0 – 1.12 1.0 – 1.04
14.3 – 1.60 12.8 – 1.40 1.4 – 0.96 2.2 – 1.53 3.0 – 1.59 0.8 – 0.75
7.51 – 1.98 6.69 – 1.42 0.81 – 0.93 2.60 – 0.98 3.23 – 1.45 0.63 – 0.85
7.55 – 1.33 6.63 – 1.19 0.92 – 1.23 2.46 – 1.30 3.73 – 1.1 1.26 – 0.88
6.86 – 0.90† 1.86 – 0.56† 2.43 – 0.79† 2.29 – 0.49* 3.14 – 0.9* 0.86 – 0.6*
6.36 – 1.18† 1.50 – 0.29† 2.07 – 0.45† 2.0 – 0.82* 4.14 – 0.3* 2.14 – 0.6*
4.73 – 0.81 2.61 – 0.74 2.11 – 1.04 3.15 – 0.75 3.85 – 0.75 0.69 – 0.83
4.85 – 0.62 2.92 – 0.95 1.92 – 0.93 2.73 – 0.78 3.19 – 0.75 0.46 – 0.63
4.88 – 0.86 1.21 – 0.40 3.67 – 0.75 1.79 – 1.27 2.6 – 1.02 0.81 – 0.96
4.94 – 0.81 2.25 – 1.14 2.69 – 1.32 1.54 – 1.16 1.88 – 0.93 0.33 – 1.05
ND ND ND 0.6 – 0.87 4.7 – 1.92 4.1 – 1.79
ND ND ND 0.8 – 0.59 4.8 – 1.16 4.1 – 1.25
ND ND ND 0.68 – 0.26 3.25 – 0.89 2.59 – 0.92
ND ND ND 0.57 – 0.41 6.15 – 0.49 5.57 – 0.44
* SD values calculated from patient data.
† CAL + SD calculated from given individual patient data.
‡ SD calculated from the square root of the sum of the variances of the measures (assuming the covariance between therapies was zero).
KT = keratinized tissue; BL = baseline; ND = no data could be retrieved.
§ Revman Metaview, Cochrane Collaboration, Oxford, U.K.
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Figure 1.
Meta-analysis of recession coverage comparing ADM versus connective tissue grafting procedures. *Aichelmann-Reidy et al.35; †Novaes et al.41;
‡Tal et al.42; §Barros et al.40
Figure 3.
Meta-analysis of clinical attachment levels comparing ADM versus coronally advanced flap procedures. *Cortes et al.43; †Woodyard et al.27
Figure 2.
Meta-analysis of keratinized tissue augmentation comparing ADM versus connective tissue grafting procedures. *Aichelmann-Reidy et al.35;
†Novaes et al.41; ‡Tal et al.42; §Barros et al.40
Figure 4.
Meta-analysis of keratinized tissue augmentation comparing ADM versus free gingival grafting procedures. *Harris34; †Wei et al.29
Acellular Dermal Matrix for Mucogingival Surgery Volume 76 • Number 11
1818
the included studies, two did not report comparisons
between groups at baseline,27,29 while the remaining
investigations found no statistically significant (NS)
differences between groups at baseline for any of
the studied parameters.27,29,34,35,40-43
ADM-Based Root Coverage Versus Connective
Tissue Graft
The results of four studies that compared ADM versus
CTG totalized 60 sites for the ADM group and 60 sites
for the CTG group. The combined data indicated no
statistically significant differences between groups
in terms of recession coverage (0.41 mm favoring
ADM-RC; test for overall effect, P = 0.39 and 95% CI
[-1.33, 0.52]; chi-square for heterogeneity, 20.78
[df = 3], P = 0.0001, and I2 = 85.6%). Considering
the high heterogeneity values among the studies, it
is interesting to note that three out of four studies
favored the ADM-RC group (Fig. 1). Changes in prob-
ing depths were minimal for all studies, with a mean
increase of 0.02 mm (not significant; test for overall
effect, P = 0.89 and 95% CI [-0.28, 0.24]; chi-square
for heterogeneity, 3.78 [df = 3], P = 0.29, and I2 =
20.6%), and may be reflective of the shallow mean
probing depths at baseline. In addition, CTG groups
had trends of increased keratinized tissue compared
to the ADM-RC group. The differences were not statis-
tically significant by random effect meta-analysis
(0.52 mm favoring CTG; test for overall effect, P =
0.11 and 95% CI [-0.12, 1.16]; chi-square for hetero-
geneity, 9.45 [df =3],P =0.02, and I2=20.6%) (Fig. 2).
Reports of clinical attachment levels were not ana-
lyzed due to possible errors in CAL calculations found
in two out of the four studies.40,41
ADM-Based Root Coverage Versus Coronally
Advanced Flap
The results of four studies that compared ADM-RC
versus CAF totaled 25 sites for the ADM group and
25 sites for the CTG group. The results revealed no
statistically significant differences between groups
in terms of recession coverage (0.62 mm favoring
ADM-RC; test for overall effect, P = 0.28 and 95%
CI [-0.74, 0.51]; chi-square for heterogeneity, 6.20
[df = 1], P = 0.01, and I2 = 83.6%), probing depths
(0.00 mm; test for overall effect, P = 0.99 and 95%
CI [-0.36, 0.35]; chi-square for heterogeneity, 0.92
[df = 1], P = 0.34, and I2 = 0%), or clinical attachment
levels (0.56 mm favoring ADM-RC; test for overall ef-
fect, P = 0.16 and 95% CI [-1.33, 0.21]; chi-square for
heterogeneity, 1.83 [df = 1], P = 0.18, and I2 = 45.2%)
(Fig. 3). In addition, two out of two studies favored
ADM-RC in augmentation of keratinized tissue
(0.31-mm difference), but the results were not statis-
tically significant (test for overall effect, P = 0.19 and
95% CI [-0.78, 0.15]; chi-square for heterogeneity
0.25 [df = 1], P = 0.62, and I2 = 0%).
ADM-Based Increase in Keratinized Tissue
Versus Free Gingival Graft
The results of two randomized clinical trials29,34 that
compared ADM versus FGG for an increase in KG
are summarized in Figure 4. One study did not report
PD and CAL changes34; therefore, only KG changes
were included in this analysis. There were a total of
21 grafts for the ADM group and 21 grafts for the
FGG group. The results demonstrated no statistically
significant differences between groups and high levels
of heterogeneity among studies (1.51 mm favoring
FGG; test for overall effect, P = 0.31 and 95% CI
[-1.41, 4.43]; chi-square for heterogeneity, 18.08
[df = 1], P <0.0001, and I2 = 94.5%).
DISCUSSION
Acellular dermal matrix allograft is processed from
human donor skin obtained from approved tissue
banks. The donor tissue is prepared by removing
the epidermis and cellular components of the skin.24
The remaining dermal layer is washed in detergent
solutions to inactivate viruses and reduce rejection.
The remaining acellular collagen matrix is then cryo-
protected and rapidly freeze-dried in a proprietary
process to preserve the biochemical and structural in-
tegrity. ADM became widely utilized in the grafting of
burn patients during the 1990s.23 The medical com-
munity has expanded its use to include tympanic
membrane reconstruction,44 nasal reconstruction,45
treatment of dermal atrophy,46 repair of fistulae,47
and facial esthetic plastic surgery applications.48,49
Shulman50 was the first author to document the use
of ADM in dentistry. Intraorally, ADM has since been
utilized in a wide range of dental applications such as
soft tissue augmentation,51 augmentation of kerati-
nized gingiva,29 as a barrier membrane,52 as a soft
tissue grafting material to cover amalgam tattoos,
and for root coverage procedures. The focused ques-
tion of this meta-analysis was as follows: In patients
with gingival recessions and/or lacking keratinized
tissue, is there a benefit in treating the patient with
acellular dermal matrix as compared to traditional
treatment modalities in regards to relevant clinical
parameters?
Thismeta-analysis did not demonstrate differences
betweenADMversusCTGandADMversusCAF for re-
cession coverage. In fact, the analysis for recession
coverage between ADM and CTG indicated statistical
heterogeneity,whereasaglanceat the forest plot (Fig.
1) demonstrated that three out of four studies had
outcomes that favored acellular dermal matrix proce-
dures. Itmust be emphasized that the studies included
in theanalysiswereshort-terminnature(£12months).
It has been recently demonstrated that ADM-based
root coverage has broken down over the long-term
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(4 years) as compared to short-term results (4
months).26This study has found a statistical superior-
ity of connective tissue graft compared to ADM at 4
years but not at 4 months. The selected publications
utilized in thismeta-analysishavenot reached thepos-
sible breakdown effect of ADM yet, reporting compa-
rableresults toCTG.More importantly,dueto thesmall
number of studies included in this meta-analysis, the
validity of drawing conclusions about the efficacy of
ADM for root coverage in comparison to other com-
mon mucogingival surgeries from the available data
is questionable. It also remains difficult to speculate
how the inclusion of more randomized studies and
longer-termdatawould affect the results. Researchers
should consider extended data rather than the stan-
dard 6 to 12 months performed in mucogingival sur-
gery to investigate the possible instability of ADM.
With regards to augmentation of KG, the result ob-
tained from this meta-analysis showed trends of more
keratinized tissue formation inCTGcompared toADM
(not significant). Similar but smaller trends were also
noted betweenADMandFGG.Histological character-
istics of ADM and its healing process may explain the
lack of keratinization. Karring et al.53 suggested that
the genotype of underlying connective tissue would
determine the characterization of the epithelium. In
this investigation, the autogenous connective tissue
originated from thekeratinizedgingivaandwasplaced
onto non-keratinized alveolar mucosa, which subse-
quently gained the keratinized features of the gin-
giva53; based on the results of this study, that could
be speculated as a possible mechanism for the lack
of KG seen in ADM-treated sites. Histological data
has demonstrated an inflammatory response within
the grafted tissue that resembles a foreign body reac-
tion.30Furthermore, the resultant tissue types of ADM
were similar to ‘‘scar’’ tissue.30 Therefore, the trans-
plantationof anon-vital graft originating fromagenet-
ically different individual and genetically different
epithelium (dermis) may lack the inherent ability to
direct differentiation of the surface oral epithelium.
The process of remodeling to generate the scar-like
tissuemay also lead to wound contracture. One study
found that ADM showed significantly greater shrink-
age than FGG treated sites 6months after graft place-
ment (71% versus 16%).29 Further randomized
clinical trials are necessary to unravel this possible
phenomenon.
The purpose of a meta-analysis is to help under-
stand and quantify sources of variability in results
across studies. It is important to note that a bias
may be introduced in the selection of articles in any
meta-analysis. The predetermined inclusion and ex-
clusion criteria of this study resulted in the utilization
of a small percentage of the total number of studies
available (eight out of 40). The most common reason
for exclusion among studies was the lack of random-
ization and lack of data required for analysis. Many
other studies were also mainly descriptive in nature
and did not report the parameters required based on
the inclusion criteria. It is also unknown how many
studies were excluded for being reported in other lan-
guages and how they would impact the data. Even
considering all the including and excluding factors,
it must be emphasized that the majority of the analy-
ses demonstrated moderate to high statistical hetero-
geneity values, indicating that there are sufficient
differences between the studies that were compiled
for this analysis. Therefore, this means that differ-
ences between treatment groups or trends toward one
therapy should be interpreted with extreme caution.
This limits the applicability of this study, and the clin-
ical significance of these findings may be limited at
best. There are a number of suggestions that may
be made as a result of this review, the majority of
which are based on the quality of reporting of clinical
trials. Researchers may consider: 1) performing ran-
domized controlled trials involving ADM comparing
to other mucogingival procedures, 2) stating the
method of randomization, 3) calculating a sample
size, 4) stating clear inclusion and exclusion criteria
of patients, 5) attempting to make studies single-
masked, and 6) utilizing longer-term data (more than
12 months).
CONCLUSIONS
Within the limitations of this study,ADM-basedmuco-
gingival surgery can be used successfully to repair
gingival recession defects and to increase keratinized
gingiva. Despite all the trends presented in this study,
differences in study design and lack of data precluded
an adequate and complete pooling of data for a more
comprehensive analysis. In summary, it is difficult to
draw anything other than tentative conclusions from
this systematic review of ADM for mucogingival sur-
gery, primarily because of weaknesses in the design
and reporting of existing trials.
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